Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

The Food and Drug Administration's new AI tool, Elsa, is reportedly generating false studies, raising concerns about the ...

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

The FDA's 'Elsa' AI, intended to speed up drug approvals, is reportedly fabricating studies, part of a wider trend of unreliable AI in high-stakes roles.

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

Despite ambitions to streamline regulatory review, FDA’s Elsa platform has been prone to hallucinations, prompting internal scrutiny and questions about AI reliability and governance.

Y ou'd have to be a special kind of Luddite to think that artificial intelligence won't change health care. The word ...

There’s no questioning that AI should have governance and guardrails. As much good as it can bring, it also heightens risk.